INTRODUCTION
Mycobacteria are the causative agents of a number of important human diseases, including tuberculosis (Mycobacterium tuberculosis) and leprosy (M. leprae). Of the 1.86 billion people that are thought to be infected with M. tuberculosis, 16 million have active disease, resulting in more than 2 million deaths per year [1] . A very limited number of antibiotics are effective against M. tuberculosis, and the incidence of drug-resistant isolates is increasing. Consequently, there is an urgent need for new antimycobacterial drugs.
All mycobacteria are surrounded by a compositionally unique cell wall that is essential for the survival of pathogenic species in the phagolysosomes of human macrophages. The mycobacterial cell wall comprises a core complex of covalently linked peptidoglycan, arabinogalactan polysaccharide and longchain mycolic acids (for reviews, see [2] [3] [4] ). Additional glycoand phospho-lipids may be incorporated into this structure or form a distinct outer lipid layer that intercalates into the layer of mycolic acids. Mannose-containing glycolipids, including the phosphatidylinositol mannosides (PIMs) and their hypermannosylated derivatives, lipomannan (LM) and lipoarabinomannan (LAM) are a major class of cell-wall glycolipids in all mycobacteria (Scheme 1B) [5] [6] [7] . The PIMs, LM and LAM are thought both to be incorporated into the plasma membrane and to be exposed on the cell surface [8, 9] . There is a large body of evidence to suggest that the PIMs and LAM can act as ligands for host-cell receptors and contribute to the pathogenesis of M. tuberculosis [5, 9, 10] . However, the presence of these glycolipids Abbreviations used: cfu, colony-forming units; DIG, digoxygenin; HPTLC, high-performance TLC; Kan, kanamycin; LAM, lipoarabinomannan; LB, LuriaBertani; LM, lipomannan; MALDI-TOF, matrix-assisted laser-desorption-ionization time-of-flight; MGLP, methylglucose lipopolysaccharide; (m/p)MMP, (mature/precursor) methylmannose polysaccharide (note: MMP does not, in the present paper, stand for matrix metalloproteinase); ORF, open reading frame; PIM, phosphatidylinositol mannosides; (di)acylPIMX , PIM species with one or two ester-linked fatty acids on the first mannose residue (linked to C-2 of inositol) or the inositol headgroup of the diacyl phosphatidylinositol lipid moiety and a total of X mannose residues; PMI, phosphomannose isomerase; Str, streptomycin. 1 These authors are equal senior investigators in the present study. 2 To whom correspondence should be addressed (e-mail malcolmm@unimelb.edu.au).
The sequence of the manA open reading frame from M. smegmatis mc 2 155 genomic DNA has been submitted to the DDBJ, EMBL, GenBank R and GSDB Nucleotide Sequence Databases under the accession number AF527174.
in saprophytic species of mycobacteria suggest that they may have more general, but as yet undefined, roles in cell-wall biogenesis and growth. This notion is supported by the finding that enzymes involved in inositol metabolism, phosphatidylinositol synthesis and PIM synthesis appear to be essential for the viability of the rapidly growing species M. smegmatis [11] [12] [13] .
Pathogenic and non-pathogenic species of mycobacteria synthesize a second major class of mannose-containing glycoconjugates termed the methylmannose polysaccharides (MMPs). The MMPs are cytoplasmic polysaccharides comprising linear chains of α1-4-linked mannose and 3-O-methylmannose residues (Scheme 1C) [14] . These polysaccharides adopt a helical conformation with a hydrophobic core that may accommodate a single fatty acid [15] . In vitro studies suggest that the MMPs can enhance the activity of the fatty acid synthase [16, 17] and thus be indirectly involved in plasma-membrane and/or cellwall synthesis. However, a M. smegmatis mutant with very low levels of MMP only exhibited subtle changes in fatty acid composition, and very little is known about the function of MMPs in vivo [18] . Finally, a limited number of glycoproteins in pathogenic and non-pathogenic species of mycobacteria are modified with short, O-linked mannose chains [19, 20] . The function of protein mannosylation in mycobacteria is also unclear.
In the present study we generated a strain of M. smegmatis that lacks phosphomannose isomerase (PMI), a key enzyme in mannose metabolism. PMI is encoded by the manA gene and catalyses the interconversion of fructose 6-phosphate and mannose 6-phosphate, which is the only pathway for the de novo synthesis of mannose (Scheme 1A). We hypothesized that the PMI deletion mutant should not be able to synthesize mannose-containing molecules in the absence of an exogenous source of mannose. Analysis of this mutant showed that mannose metabolism is essential for growth of M. smegmatis and suggested that mannose-containing molecules may have a role in regulating septation and cell division without perturbing other pathways of lipid biosynthesis.
EXPERIMENTAL

Bacterial strains and growth conditions
Escherichia coli XL-1 Blue MRF (Stratagene), M. smegmatis mc 2 155 [21] and derivative strains were grown in LuriaBertani (LB) medium at 37
• C. The MAN1 mutant was routinely cultivated in LB media containing 5 mM mannose. For biochemical studies, mycobacterial strains were grown in M9 minimal medium [22] with 0.05 % v/v Tween 80. Streptomycin (Str) and kanamycin (Kan) (20 µg/ml), ampicillin (100 µg/ml) and 10 % (w/v) sucrose were added as required. Cultures were also supplemented with 5 mM mannose where indicated.
Cloning and genetic manipulation
Cloning procedures were performed according to standard protocols [22] . Electrotransformation was performed using a Bio-Rad Gene Pulser, and E. coli cells were prepared for transformation according to the manufacturer's recommendations. M. smegmatis cells were prepared for electrotransformation as previously described [21] . Genomic DNA was extracted as previously described [23] . Probes for Southern blotting were labelled with digoxygenin (DIG)-labelled dNTPs using a Roche DIG labelling kit, and membranes were developed according to the manufacturer's instructions. Restriction endonucleases and DNAmodification enzymes were obtained from Pharmacia.
Disruption of the manA gene in M. smegmatis PCR was employed to amplify 1 kbp regions flanking the manA open reading frame (ORF) from M. smegmatis mc 2 155 genomic DNA. The primer pairs A (5 -CCGGAATTCA-TGGCGGGGGCCCAGGTGCGGG-3 ) and B (5 -GAATTGG-TTCGAGGTTAAACGACCCGGGCGGCGC-3 ) were used for the upstream region, and C (5 -AAACGACCCGGGCGGCGCT-GCACCGCCACCGCAC-3 ) and D (5 -CTAGTCTAGACGGT-GCTGCGCGCGGCGGGGTCGC-3 ) were used for the downstream region. The amplicons were annealed, relying on 6 bp of complementarity introduced with primers B and C, and used as a template for spliced overlap extension PCR using primers A and D. The resultant 2 kbp amplicon was cloned into pBluescript SK(+) using EcoRI and XbaI restrictionendonuclease recognition sites included in primers A and D, creating pJP3873. A Str-resistance gene [24] was cloned into pJP3873 at a unique Sma1 site, creating pJP3874. The resulting recombination cassette was subcloned from pJP3874 into pKmobsacB [24] using EcoRI and XbaI sites to create the homologous recombination construct pJP3875. This plasmid was electroporated into M. smegmatis mc 2 155, and mutants that had undergone consecutive rounds of homologous recombination were finally selected on the basis of Str-resistance, growth in the presence of sucrose and Kan-sensitivity. A complementation vector was constructed after PCR amplifying the manA ORF from M. smegmatis mc 2 155 genomic DNA using the primer pair E (5 -GCGGATCCAGTGCATCTGCTACGGGGA-3 ) and F (5 -TTGGATCCACAAGAGCCTGGCCGCCAC-3 ). These primers included BamHI restriction-endonuclease recognition sites. The amplicon was cloned into the mycobacterial shuttle vector pMV261 [25] using the unique BamHI site, creating the manA complementation vector pJP3876. The pJP3876 and pMV261 (control) plasmids were introduced into M. smegmatis mc 2 155 and MAN1 by electrotransformation.
Monitoring growth/viability
Mycobacterial growth was followed by measuring colonyforming units (cfu), monitoring attenuance (D 600 ) of cultures or by measuring the total protein concentration [26] . Culture viability was assessed by adding 25 µM [5, H]uracil (0.8 µCi, 33.1 Ci/mmol; PerkinElmer Life Sciences) to a 1 ml aliquot of the culture. After a 10 min incubation, cells were washed twice with PBS, lysed with 1 M NaOH at 100
• C and radioactivity measured by liquid-scintillation counting after neutralization with 5 M HCl.
PMI assays
Cytosolic extracts of mycobacteria were obtained by sonication (MSE Soniprep 150 instrument; 10 × 30 s at 25 µ, 0
• C) in 50 mM Hepes/NaOH (pH 7.4), containing 2 mM EGTA, 2 µM leupeptin, 0.1 mM PMSF and 0.1 mM
). Intact cells were removed by centrifugation (13 000 g, 10 min) and PMI activity measured as described previously [27] .
Metabolic labelling
M. smegmatis mc 2 155 or MAN1 cells were grown to midexponential phase in M9 medium containing 5 mM mannose, washed in M9 media (minus mannose), then pulse-labelled with [2- 3 H]mannose (50 µCi/5 ml; 17 Ci/mmol; ICN) in M9 medium for 30 min. Mycobacteria were harvested by centrifugation and equal aliquots suspended in M9 media (10 ml) with or without 5 mM mannose. Aliquots (1 ml) were removed at indicated time points for analysis. M. smegmatis mc 2 155 and MAN1 were also continuously labelled for 6-20 h with myo- [2- 3 H]inositol (25 µCi/5 ml; 17 Ci/mmol; Amersham Pharmacia), [1- 14 C]acetate (50 µCi/5 ml; Amersham Pharmacia) or L-[methyl-
3 H]-methionine (25 µCi/5 ml; PerkinElmer Life Sciences) after being preincubated in the presence or absence of mannose for 9 h. Uptake of L-[methyl-
3 H]methionine required the addition of a mixture of MEM amino acids (Gibco) to the M9 medium (1 ml in 200 ml of medium) prior to labelling.
Preparation of PIM, LAM and MMP fractions
PBS-washed cell pellets were extracted twice with chloroform/methanol (2:1, v/v) then chloroform/methanol/water (1:2:0.8, by vol.). Water was added to the combined supernatants to give final chloroform/methanol/water proportions of 1:2:1.4 (by vol.) and the upper phase, containing both PIM and MMP, was dried under a stream of N 2 gas, resuspended in 0.1 M ammonium acetate containing 5 % (v/v) propan-1-ol and loaded on to a small column (500 µl) of octyl-Sepharose (Amersham Pharmacia) equilibrated in the same buffer. MMP was eluted in 0.1 M ammonium acetate containing 5 % propan-1-ol (2 ml), whereas PIM was eluted with 30, 40 and 50 % propan-1-ol (1 ml each). The bound fractions were pooled, dried, and combined with the chloroform/methanol/water (1:2:1.4, by vol.) organic lower phase for high-performance TLC (HPTLC) analysis (PIM fraction). The unbound fractions were treated with bovine alkaline phosphatase (Sigma) in 0.1 M NH 4 HCO 3 (100 units, 37
• C, 2 h) then freeze-dried to remove buffer salts (MMP, lowmolecular-mass metabolite fraction). LM/LAM was extracted from the delipidated pellet by four refluxes in 50 % (v/v) ethanol at 100
• C. The combined 50 %-ethanol extracts were dried under N 2 and the LM/LAM purified by octyl-Sepharose chromatography as described above (LM/LAM fraction). The monosaccharide composition of these fractions was determined by GLC-MS after hydrolysis in 2 M trifluoroacetic acid (100 • C, 2 h) and conversion of the released monosaccharides into their corresponding alditol acetates [28] .
Analysis of PIM, LAM and MMP fractions
The degree of acylation of the major steady-state pools of M. smegmatis PIMs was determined using a matrix-assisted laser-desorption-ionization time-of-flight (MALDI-TOF) mass spectrometer. PIM-enriched fractions were suspended in 30 % (v/v) propan-1-ol, mixed with an equal volume of freshly prepared saturated α-cyano-4-hydroxycinnamic acid in 60 % propan-1-ol and analysed on a Voyager System 4180 MALDI-TOF mass spectrometer (PerkinElmer) in the linear negative-ion mode. The accelerating voltage was 20 000 V, the grid voltage applied was between 94 and 96 % and the guide wire voltage was 0.05 %.
Metabolically labelled PIMs were deacylated in methanolic 0.2 M NaOH for 1 h at 37
• C, and the reaction mixture neutralized with 1 M acetic acid. The samples were dried under a stream of N 2 , partitioned between butan-1-ol (400 µl) and water (200 µl) and the deacylated phosphoglycans recovered in the lower aqueous phase. The aqueous fraction was dephosphorylated in ice-cold 48 % (w/v) HF (50 µl) for 48 h and neutralized with a saturated solution of LiOH. After removal of the LiF precipitate by centrifugation, the supernatant was desalted on a mixed-bed column (400 µl) of AG50-X12 (
Metabolically labelled lipids were resolved on aluminiumbacked silica-gel-60 HPTLC sheets (Merck) developed in chloroform/methanol/1 M ammonium acetate/13 M NH 3 /water (180:140:9:9:23, by vol.). The 3 H-labelled MMPs were resolved on HPTLC sheets developed twice in the same dimension in butan-1-ol/ethanol/water (4:3:3, by vol.) [29] . The neutral glycan fractions were resolved by HPTLC by development in propan-1-ol/acetone/water (9:6:5, by vol.) [29] . Radiolabelled components were detected by fluorography after coating the HPTLC sheets with EA Wax (EA Biotech, Clarkston, Glasgow, Scotland, U.K.) and exposure to BioMax MR film (Kodak) at − 80
• C.
Electron microscopy
M. smegmatis mc 2 155 or MAN1 cells were washed in PBS, fixed with glutaraldehyde (2.5 %) (ProSciTech, Thuringowa Central, Qld, Australia) and Ruthenium Red (0.05%) in PBS (2 h, 4
• C), then sequentially washed in dilutions of PBS (100, 66, 50, 33 and 0 %) in water. Bacteria were post-fixed with 1 % (w/v) OsO 4 and Ruthenium Red (0.05 %) in water (2 h, 4
• C), washed in water, then pelleted into agarose (1 % at 60
• C) and dehydrated in a graded acetone series over 20 h. After embedding in Spurrs resin [30] , ultrathin sections were cut using a Leica Ultracut R microtome. Sections were stained with uranyl acetate (20 min) and Reynold's lead citrate stain (4 min) and observed using a Philips CM120 BioTWIN transmission electron microscope.
RESULTS
Disruption of manA in M. smegmatis
Possible homologues of the genes encoding PMI (manA), phosphomannomutase (pmmA, pmmB) and GDP-mannose pyrophosphorylase (rmlA2) occur in the genomes of M. tuberculosis, M. leprae and M. smegmatis (Scheme 1A), suggesting that the pathway of mannose metabolism in mycobacteria is similar to that found in all eukaryotes. The ORF of the M. smegmatis manA gene contained 1227 bp and encoded a predicted 408-amino-acid protein. Comparative analysis of the amino acid sequence of the putative PMI proteins from M. smegmatis with other homologues showed it to possess 74-76% sequence identity with the M. tuberculosis and M. leprae PMI enzymes and 24 % identity with human PMI.
As PMI is expected to be essential for the de novo synthesis of mannose, we hypothesized that targeted deletion of manA should convert the wild-type strain, mc 2 155, into a mannose auxotroph. The manA deletion mutant was made using a recombination construct containing the Str-resistance gene (Str) flanked by 1 kbp of non-coding sequence from either side of the manA gene ( Figure 1A) . Genes for kanamycin resistance and levansucrase were included on the vector portion of the recombination construct. After two rounds of selection for single and double homologous recombination events, several viable colonies were recovered on mannose-containing plates. Southern-blot analysis of Pst1 digests confirmed that these colonies lacked a genomic copy of manA ( Figure 1B) . One of these, designated MAN1, was chosen for further analysis. MAN1 lacked detectable PMI enzymic activity (< 400 times that in mc 2 155) ( Figure 1C ). However, complementation of both MAN1 and wild-type mc 2 155 with a plasmid containing M. smegmatis manA under the control of a GroEL promoter, resulted in high levels of PMI activity in both strains ( Figure 1C ). These studies showed that the M. smegmatis manA gene encoded an active PMI enzyme and that this gene has been successfully disrupted in MAN1.
Mannose is essential for the growth of MAN1 cells
The growth rate of the MAN1 strain was compared with wildtype mc 2 155 in M9 medium with or without mannose. When stationary-phase MAN1 cells were inoculated into fresh medium containing 5 mM mannose, they grew at the same rate as wildtype mc 2 155 (Figure 2A ). However, in the absence of exogenous mannose, growth ceased after one or two cell divisions, as determined by measurements of D 600 (Figure 2A) , protein yield and cfu (results not shown). Growth of MAN1 in M9 medium required at least 5 µM exogenous mannose and was not inhibited by concentrations up to 50 mM (results not shown).
Complementation of MAN1 with an episomal copy of manA restored prototrophy ( Figure 2B ) and wild-type growth rates (results not shown). We next examined whether MAN1cells remained viable during mannose starvation. MAN1 cells were grown to mid-exponential growth phase in M9 medium containing 5 mM mannose, than resuspended at the same cell density in fresh media with or without mannose. The MAN1 cells inoculated into mannose-containing media continued to grow, while bacteria in the medium lacking mannose did not divide and started to lose viability rapidly after 10 h ( Figure 2C ). The loss of viability was preceded by a decrease in metabolic activity, as indicated by uptake of [5, 6- 3 H]uracil ( Figure 2D ). These results suggested that mannose metabolism was essential for both the growth and viability of rapidly dividing M. smegmatis.
Mannose glycoconjugate biosynthesis and catabolism in MAN1
We next examined the biosynthesis and catabolism of mannosecontaining glycoconjugates in MAN1 grown in the presence and absence of mannose. MAN1 cells in mid-exponential growth phase were pulse-labelled with [2- 3 H]mannose in M9 medium, then resuspended in fresh medium with or without exogenous mannose. As shown in Figure 3 (A), [ 3 H]mannose was initially incorporated into a number of PIM precursor species which 'chased' into mature PIMs within 2 h when pulse-labelled cells were suspended in medium with 5 mM mannose. These mature PIM species were shown to be acyl and diacyl species of PIM2 and PIM6 by MALDI-TOF MS of steady-state pools ( Figure 4A ) and HPTLC analysis of both the native in media without mannose, the 3 H label was not chased into mature end products ( Figure 3A) . Significantly, label in the earliest PIM species detected in these analyses, acyl-PIM1, was very inefficiently chased over 20 h ( Figure 3A) . These results showed that the conversion of precursor glycolipids into mature PIMs is effectively halted in the absence of exogenous mannose. The flux of [ 3 H]mannose into mature MMPs was also halted in the absence of exogenous mannose. After a short pulse, the non-lipidic MMPs were resolved as a ladder of bands by HPTLC ( Figure 3B ). The bands with the slowest HPTLC mobility were shown by GLC-MS compositional analysis to contain mannose and 3-O-methylmannose and co-migrated with mature MMP (mMMP) (results not shown). The faster-migrating species are likely to be MMP precursors (pMMP) as 3 H label in these species rapidly chased into mMMP in the presence of exogenous mannose ( Figure 3B ). These species were also labelled with [methyl-
3 H]methionine ( Figure 5C ), which is converted into S- adenosylmethionine and used to methylate mannose residues in the elongating MMP chains [31] . Significantly, [ 3 H]mannose label in the pMMP did not chase into mMMP when pulse-labelled cells were suspended in medium without mannose ( Figure 3B ), demonstrating that synthesis of the MMPs is also rapidly halted in the absence of exogenous mannose.
MAN1 were also continuously labelled with [ 3 H]inositol and [methyl-
3 H]methionine to measure de novo synthesis of PIM/LAM and MMP respectively. Incorporation of [ 3 H]inositol into the PIMs, but not phosphatidylinositol and lysophosphatidylinositol species, was completely inhibited when MAN1 cells were preincubated for 9 h in media lacking exogenous mannose ( Figure 5A ). Incorporation of [methyl-3 H]methionine into MMP was also greatly reduced in the absence of exogenous mannose ( Figure 5C ). However, incorporation of [ 3 H]inositol into LAM was only reduced by ≈ 60 % in the absence of exogenous mannose ( Figure 5B ). The residual incorporation of [ 3 H]inositol in the absence of exogenous mannose may reflect the addition of inositol to the non-reducing termini of pre-existing pools of mature LAM [32] . Collectively, these results suggested that biosynthesis of all mannose-containing molecules is rapidly halted in the absence of an exogenous source of mannose.
The pulse-chase labelling experiments also showed that none of these glycoconjugates are catabolized during mannose starvation.
MAN1 cells exhibit a hyperseptation phenotype
We next examined whether the growth phenotype of mannosestarved MAN1 was associated with changes in either cellwall permeability or structure. Mannose-starved MAN1 cells did not exhibit increased sensitivity to the hydrophobic drugs, rifampicin or novobiocin, compared with mannose-replete MAN1 or mc 2 155, indicating that cell-wall permeability had not changed dramatically (results not shown) [33] . Furthermore, there was no evidence for general perturbation of cell-wall structure in thin sections of mannose-starved MAN1 (Figures 6A and 6B) . However, MAN1 cells were significantly shorter than wild-type (Figures 6C-6G ). In the presence of mannose, approximately a quarter of MAN1 cells (24/100 cells) contained a septum, compared with < 1 % of wild-type mc 2 155 ( Figure 6G) cells. An increase in the number of complete or incomplete septa was evident after exponential-phase MAN1 cells were suspended in medium lacking mannose for 3 h, and nearly all cells contained one or more septa after 17 h (174 septa/100 cells) ( Figure 6G ). The septa in these cells were often incomplete and/or were distorted ( Figures 6E and 6F ). Mannose-starved MAN1 also released large amounts of extracellular material that accumulated in the interstitial spaces of cell clumps ( Figure 6C ). This material was not detected in MAN1 grown in the presence of mannose or in wild-type cells (results not shown). As the hyperseptation phenotype was evident when cells were grown in the presence of mannose, and was rapidly exacerbated in the absence of exogenous mannose, it is likely to be an early consequence of perturbations in mannose metabolism. 
Inhibition of mannoglycoconjugate biosynthesis does not affect fatty acid synthesis
A similar hyperseptation phenotype can be induced by treating mycobacteria with inhibitors of fatty acid biosynthesis [34] . Given that cytoplasmic MMPs are thought to regulate the activity of fatty acid synthases [16, 17] , we investigated whether fatty acid biosynthesis was affected in mannose-starved MAN1. As shown in Figure 5 , the biosynthesis of phosphatidylinositol was not affected in mannose-starved MAN1. To extend this observation, MAN1 cells were incubated in the presence or absence of mannose for 10 h, then continuously labelled with [ 14 C]acetate. As shown in Figure 7 , the de novo synthesis of the major phospholipid classes was quantitatively and qualitatively similar in the presence or absence of mannose. In contrast, the synthesis of the major PIM species, acyl-PIM2, was greatly decreased in mannosestarved MAN1 (Figure 7 , second lane). This result suggests that perturbation of mannose metabolism does not result in gross changes in fatty acid biosynthesis.
DISCUSSION
Mannose is a key component in several cell-wall and intracellular molecules in mycobacteria, including an abundant family of mannolipids (PIM/LM/LAMs), a cytoplasmic MMP, and a limited number of O-mannosylated glycoproteins. These molecules are synthesized by both pathogenic and non-pathogenic species of mycobacteria, raising the possibility that they fulfil important, but as yet undefined, 'housekeeping' functions in these organisms. In the present study we have generated a M. smegmatis mannose auxotroph by targeted deletion of the manA gene encoding PMI. When grown in the presence of an exogenous supply of mannose, the MAN1 cells grew at the same rate as wild-type M. smegmatis, but were significantly shorter than wild-type cells and displayed a mild hyperseptation phenotype. When suspended in medium lacking mannose, this hyperseptation phenotype became more pronounced and cell division ceased. These changes preceded the exponential loss of viability that occurred after 10 h in mannosefree medium. Disruption of mannose metabolism thus appears to have an early effect on processes involved in septation and cell division and subsequently leads to loss of viability.
The phenotype of the MAN1 mutant is likely to be due to perturbations in the rate of synthesis of mannose-containing molecules. Specifically, the processing of prelabelled PIMs and MMP intermediates was immediately halted when exponentialphase MAN1 cells were suspended in mannose-free medium, suggesting that intracellular pools of mannose precursors (mannose 6-phosphate, GDP-mannose) are rapidly depleted under these conditions. In contrast, stationary-phase cells underwent one or two cell doublings when suspended in mannose-free media (as shown by increase in both cfu and cellular protein) before cell division ceased (Figure 2A) . Stationary-phase cells may contain higher steady-state levels of either the mannose precursors and/or mannose-containing glycoconjugates to allow a limited number of cell divisions in the absence of ongoing mannose metabolism. Interestingly, these analyses showed that there was very little turnover of PIM or MMP precursors or end products during the 20 h mannose starvation period. A similar lack of turnover of metabolically labelled intermediates was observed if MAN1 or wild-type cells were suspended in media lacking a carbon source (J. H. Patterson and M. J. McConville, unpublished work). These results are consistent with the notion that these very abundant cellular components are metabolic end products and do not have a significant reserve function.
Our finding that mannose metabolism is essential for growth of M. smegmatis is supported by the studies of Jackson and colleagues [12, 13] , who recently showed that pgsA and pimA (encoding phosphatidylinositol synthase and the first mannosyltransferase in PIM biosynthesis respectively), are also required for growth and viability of M. smegmatis. The loss of viability of MAN1 cells in the absence of exogenous mannose is thus likely to be due, at least partly, to the cessation of PIM biosynthesis. While the precise role of the PIMs and LAMs in mycobacterial cell-wall biogenesis and growth remain unclear, it is possible that they are essential bulk components of the cell wall and/or that they modulate specific processes in plasmamembrane and cell-wall compartments. Our current analyses suggest that the growth defect in mannose-starved MAN1 is not due to gross changes in the steady-state pools of PIM or LAM, or the rate of synthesis of other cell-wall and plasma-membrane phospholipids. The permeability of the mannose-starved MAN1 was also unchanged, as indicated by the sensitivity of the mutant to the hydrophobic drugs rifampicin and novobiocin. In contrast, M. smegmatis mutants with defects in arabinogalactan biosynthesis displayed significantly increased sensitivity to these drugs [33] . While these results do not preclude the possibility that the PIMs and LAM are important bulk plasma-membrane or cell-wall components, they raise the possibility that one or more of these glycolipids may have a more direct role in regulating processes involved in cell division or cell viability.
The phenotype of the mannose auxotroph could also reflect changes in the steady-state levels or rate of biosynthesis of other mannose-containing molecules, such as the intracellular pools of MMP [16, 17] or O-mannosylated glycoproteins [19, 35] . In this respect we have recently found that selective disruption of PIM biosynthesis in an M. smegmatis inositol auxotroph, in the presence of ongoing MMP biosynthesis and protein glycosylation, have been shown to sequester fatty acyl-CoAs in in vitro assays and could directly or indirectly affect the properties of the plasma membrane and cell wall by regulating fatty acid synthesis [16, 17] . However, depletion of cellular levels of both MMP and MGLP in M. smegmatis (to 7 and 50 % of wild-type levels respectively) had no effect on growth, and only resulted in subtle changes in fatty acid composition [18] . Similarly, gross changes in the synthesis of cell-wall or plasma-membrane phospholipids were not observed when MMP synthesis was inhibited in MAN1. Furthermore, the growth phenotype of mannose-starved MAN1 was not reversed by supplementation of the culture media with fatty acids to bypass any defects in fatty acid biosynthesis (results not shown). It is possible that pre-existing pools of MMPs are sufficient to sustain normal rates of fatty acid synthesis in mannose-starved MAN1 cells and/or that the MGLPs compensate for any decrease in MMP levels.
These studies show that mannose metabolism is essential for the growth and viability of M. smegmatis, suggesting that enzymes involved in the synthesis of mannose donors, or downstream mannosyltransferases, may be potential drug targets in pathogenic species of mycobacteria. In this respect it is notable that four mycobacterial mannosyltransferases that catalyse early steps in PIM biosynthesis share little homology with the mannosyltransferases of animal cells [13, [36] [37] [38] . The mannose auxotroph characterized in the present study will provide an useful cell line for further investigating the specific functions of mannose-containing glycoconjugates in cell-wall assembly and cell division.
